| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $2,906,871 ) |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01ES036241 | Novel Epitranscriptomic Mechanisms in Metal Neurotoxicity | 000 | 1 | NIH | 11/14/2024 | $441,529 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01ES034196 | Role of Prokineticin 2 in Metal Neurotoxicity | 000 | 3 | NIH | 10/29/2024 | $339,750 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21AI182884 | Maternal vaccination impacts on neonatal susceptibility and response to Bordetella pertussis | 000 | 1 | NIH | 11/13/2024 | $212,265 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM152057 | Regulation of protein transport in cilia | 001 | 2 | NIH | 11/13/2024 | $490,327 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AG076625 | Implications of Metabolic Dysfunction during Thiamine Insufficiency | 000 | 3 | NIH | 11/14/2024 | $331,600 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AI158743 | Synthetic multi-component influenza vaccines to elicit broad immunity | 000 | 2 | NIH | 11/1/2024 | $660,492 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AI173144 | Impacts of host lipid composition on antimicrobial susceptibilities of Staphylococcus aureus | 000 | 3 | NIH | 11/4/2024 | $471,568 |
| | 2025 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM152134 | Control and function of repressive chromatin domains | 000 | 1 | NIH | 11/6/2024 | $0 |
| | 2025 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM152057 | Regulation of protein transport in cilia | 000 | 1 | NIH | 11/5/2024 | $0 |
| | 2025 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01ES034196 | Role of Prokineticin 2 in Metal Neurotoxicity | 001 | 2 | NIH | 10/30/2024 | $0 |
| | 2025 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM118160 | CRISPR Capture, Destroy, and Counter-Attack Mechanisms | 000 | 9 | NIH | 11/6/2024 | $0 |
| | 2025 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM153268 | Epigenomic consequences of breakage-fusion-bridge cycling | 000 | 1 | NIH | 11/7/2024 | $0 |
| | 2025 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | D43TW012481 | Digital Mobile Technologies to study Tuberculosis: A Multi-disciplinary Program | 000 | 2 | NIH | 11/15/2024 | $0 |
| | 2025 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | D43TW012481 | Digital Mobile Technologies to study Tuberculosis: A Multi-disciplinary Program | 000 | 2 | NIH | 11/15/2024 | $0 |
| | 2025 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | K99AI177948 | State of the ART: Functional genomics of RNA-binding proteins and their role in artemisinin drug resistance in Plasmodium falciparum | 000 | 1 | NIH | 11/14/2024 | $0 |
| | 2025 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21LM014569 | AI-MedWise: Developing and validating an artificial intelligence solution for effective video-based monitoring of medication adherence | 000 | 1 | NIH | 11/15/2024 | $0 |
| | 2025 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM148433 | O-glycosylation of cysteine-rich modules | 000 | 2 | NIH | 11/8/2024 | $0 |
| | 2025 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM139656 | Unlocking sequence-structure-function-disease relationships in large protein super-families | 000 | 4 | NIH | 11/13/2024 | $0 |
| | 2025 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM128620 | Biosensor-driven Platforms for Biosynthesis of Natural Products in Bacteria | 000 | 6 | NIH | 11/5/2024 | $0 |
| | 2025 | 2023 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01MH116039 | Prodromal Inventory for Negative Symptoms (PINS): A Development and Validation Study | 000 | 5 | NIH | 11/4/2024 | $0 |
| | 2025 | 2023 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | F30HD098828 | Defining the OGT Interactive and its Role in X-Linked Intellectual Disability - Corrected Resubmission - Stephen Pre Doc Fellowship | 000 | 4 | NIH | 10/23/2024 | -$35 |
| | 2025 | 2022 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21AI153851 | Essential function of a putative glycosyltransferase in P. falciparum | 000 | 2 | NIH | 10/29/2024 | -$2,059 |
| | 2025 | 2022 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01GM134335 | Sparse NMR Labeling Approach to Glycoprotein Structure and Function | 000 | 4 | NIH | 10/29/2024 | -$472 |
| | 2025 | 2022 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01OD028223 | Derivation of Functional Spermatogonia Stem Cells from Rhesus Macaque iPSCs | 001 | 4 | NIH | 10/23/2024 | -$6,201 |
| | 2025 | 2022 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01OD028223 | Derivation of Functional Spermatogonia Stem Cells from Rhesus Macaque iPSCs | 000 | 4 | NIH | 10/23/2024 | -$8,799 |
| | 2025 | 2022 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | 90DDUC0127 | IHDD-UCEDD FY2023-2027 | 01 | 3 | ACL | 10/18/2024 | $0 |
| | 2025 | 2021 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | 90DNIQ0002 | Living Well Georgia: A Model Program to Enhance the Quality, Effectiveness, and Monitoring of HCBS Services for Individuals with I/DD across Service Settings | 03 | 5 | ACL | 11/18/2024 | -$23,088 |
| | 2025 | 2021 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21AI158176 | Develop Potent Methyltransferase Inhibitors to Target Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) | 000 | 1 | NIH | 11/7/2024 | -$6 |
| | 2025 | 2020 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | 90DNIQ0002 | Living Well Georgia: A Model Program to Enhance the Quality, Effectiveness, and Monitoring of HCBS Services for Individuals with I/DD across Service Settings | 03 | 5 | ACL | 11/18/2024 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $65,043,795 ) (Continued on the next page) |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21HL167091 | Genome-wide Analysis of Anticoagulant Heparin Sulfate for Bioengineering Heparan | 000 | 2 | NIH | 7/16/2024 | $188,750 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01DA055630 | Early Adversity and Drug Use Vulnerability Among Low Income Rural Children: Testing a Neuro-ecological Model of Resilience | 002 | 2 | NIH | 8/5/2024 | $27,322 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | U01AG074960 | Novel Reengineered Microbiome-based Biologic Therapy to Treat Cognitive and Behavioral Symptoms of Alzheimer's Disease and Related Dementias | 002 | 3 | NIH | 8/22/2024 | $0 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01NS121692 | Compensatory Mitochondrial Protective Mechanisms Against Oxidative Stress in PD | 000 | 3 | NIH | 6/25/2024 | $422,932 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AI140719 | Cryptococcal vaccine development based on strong immunity induced by morphological strains | 000 | 6 | NIH | 4/25/2024 | $519,899 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01DA055630 | Early Adversity and Drug Use Vulnerability Among Low Income Rural Children: Testing a Neuro-ecological Model of Resilience | 001 | 2 | NIH | 4/26/2024 | $67,936 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AA026362 | The Neurokinin-1 Receptor as a Mediator of Alcoholism and Depression Comorbidity | 002 | 6 | NIH | 8/20/2024 | $363,573 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01CA271533 | Sulindac sensitizes colorectal cancer to anti-PD-L1 therapy | 000 | 3 | NIH | 7/24/2024 | $533,414 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM150916 | Molecular mechanisms of physical interactions between bacteria and their surroundings | 000 | 2 | NIH | 8/23/2024 | $368,444 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21AR080957 | Functional Genomics of Multiple Hereditary Exostoses | 000 | 1 | NIH | 9/24/2024 | $379,003 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21AI171944 | Extracellular vesicles encapsulating CRISPR machinery for treatment of SARS-CoV-2 infection | 000 | 2 | NIH | 12/5/2023 | $165,800 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM153189 | Analysis of Metabolic Stress and Functional Integration in Prokaryotes | 000 | 1 | NIH | 3/25/2024 | $252,429 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21AI171944 | Extracellular vesicles encapsulating CRISPR machinery for treatment of SARS-CoV-2 infection | 001 | 2 | NIH | 5/17/2024 | $18,422 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM150736 | Investigating the molecular mechanisms of glycosaminoglycan assembly | 000 | 2 | NIH | 5/20/2024 | $377,500 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | D43TW012481 | Digital Mobile Technologies to study Tuberculosis: A Multi-disciplinary Program | 001 | 2 | NIH | 7/11/2024 | -$50,000 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | D43TW012481 | Digital Mobile Technologies to study Tuberculosis: A Multi-disciplinary Program | 001 | 2 | NIH | 7/11/2024 | $50,000 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM152134 | Control and function of repressive chromatin domains | 000 | 1 | NIH | 7/12/2024 | $393,512 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01GM147061 | The IMPACT Study: Improving Mentorship Practice through Attributions and Conflict Training | 000 | 3 | NIH | 6/28/2024 | $298,771 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | D43TW012481 | Digital Mobile Technologies to study Tuberculosis: A Multi-disciplinary Program | 000 | 2 | NIH | 12/10/2023 | $188,034 |
|
